The Nasdaq Hearings Panel is allowing Amedica an extension to demonstrate it is in full compliance to be listed on The Nasdaq Capital Market.
Here are four points:
1. This includes the filing and the $1 closing bid price requirement.
2. The company must file its Forms 10-Q for the periods ended March 31 and June 30 with the SEC by Oct. 31 to posses continued Nasdaq listing.
3. Additionally, Amedica must show a closing bid price of $1 minimum per share for at least 10 consecutive business days by Nov. 30.
4. While Amedica is working to demonstrate compliance, it will not necessarily be able to do so in the time allotted.